Combined Research Orlando Phase I IV — Orlando, Florida

Combined Research Orlando Phase I IV is a clinical research site located in Orlando, Florida, United States 32807.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Combined Research Orlando Phase I IV has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Obesity, Alzheimer's Disease Psychosis.

Sponsors: Amgen, ACADIA Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Combined Research Orlando Phase I IV?

Combined Research Orlando Phase I IV has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Combined Research Orlando Phase I IV conducted?

Combined Research Orlando Phase I IV has 2 clinical trials on record, with 2 currently active. Their work covers Obesity, Alzheimer's Disease Psychosis.

Is Combined Research Orlando Phase I IV accredited by Crixeo Health?

Combined Research Orlando Phase I IV has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Combined Research Orlando Phase I IV?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.